Latest Commercialisation News

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Emperor Energy has raised $3.7 million through a share placement to advance the Judith-2 appraisal well in Victoria’s Gippsland Basin, backed by independent resource validation and strategic infrastructure proximity.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

The Environmental Group Limited (ASX – EGL) has landed a $1.9 million contract to design and build its inaugural PFAS treatment plant, marking a key milestone in commercialising its proprietary environmental technology.

HyTerra Limited is advancing its Nemaha Project with the imminent spudding of the McCoy 1 well, moving towards data-driven exploration backed by strategic funding from Fortescue Future Industries Technologies.

TMK Energy has secured a drilling contract for its LF-07 production well, marking a key milestone in its Lucky Fox Pilot Well Project in Mongolia. The company also outlines an ambitious 2025 exploration program aimed at expanding its coal seam gas resources.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

Green Critical Minerals’ proprietary VHD graphite heat sink outperforms traditional materials in computational tests, promising enhanced thermal management for high-power microchips in data centres.